Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development (includes related party amounts of $172, $0, $1,594 and $15, respectively)	$ 8,826	$ 460	$ 15,037	$ 727
In-process research and development			2,500
General and administrative (includes related party amounts of $8, $219, $34 and $384, respectively)	3,982	753	6,585	1,951
Total operating expenses	12,808	1,213	24,122	2,678
Loss from operating ,Total	(12,808)	(1,213)	(24,122)	(2,678)
Other income (expense):
Interest income	334		340
Interest expense (includes related party amounts of $188, $8, $717 and $17, respectively)	(888)	(8)	(2,952)	(17)
Change in fair value of convertible promissory notes (includes related party amounts of $8,818, $444, $13,196 and $517, respectively)	(34,396)	(444)	(51,469)	(517)
Change in fair value of warrant liabilities - related party	(6,151)		(43,575)
Other income (expense)	(20)	(2)	(38)	(1)
Total other income (expense)	(41,121)	(454)	(97,694)	(535)
Net loss	$ (53,929)	$ (1,667)	$ (121,816)	$ (3,213)
Net loss per share, basic	$ (2.03)	$ (0.34)	$ (7.30)	$ (0.66)
Net loss per share, diluted	$ (2.03)	$ (0.34)	$ (7.30)	$ (0.66)
Weighted-average shares of common stock outstanding, basic	26,512,881	4,935,738	16,685,372	4,869,690
Weighted-average shares of common stock outstanding, diluted	26,512,881	4,935,738	16,685,372	4,869,690